Skip to main content

Table 7 Specificity of criteria for ‘possible autoimmune encephalitis’, ‘definite autoimmune limbic encephalitis’ and ‘probable anti-NMDA receptor encephalitis’

From: Application of the 2016 diagnostic approach for autoimmune encephalitis from Lancet Neurology to Chinese patients

 

0–14 days

15–30 days

31–90 days

>90 days

P*

pAEa

83%(6/12)

92%(9/12)

92%(11/12)

92%(11/12)

0.880

dALEb

96%(43/45)

96%(43/45)

96%(43/45)

96%(43/45)

1.000

prNMDAREc

100%(34/34)

100%(34/34)

100%(34/34)

100%(34/34)

1.000

  1. * P < 0.05 is significant
  2. aspecificity of possible autoimmune encephalitis assessed by pAE(−)/non autoimmune encephalitis cases
  3. bspecificity of definite autoimmune limbic encephalitis assessed by dALE(−)/non autoimmune limbic encephalitis cases
  4. cspecificity of probable anti-NMDA receptor encephalitis assessed by prNMDARE(−)/non anti-NMDAR encephalitis cases